馃攳
Introducing Genomic Testing Cooperative (GTC) - Interview with Dr. Maher Albitar MD - YouTube
Channel: unknown
[9]
[Music]
[17]
[Music]
[25]
precision medicine require
[27]
precision diagnostics precision
[30]
diagnostic
[31]
is very important in vision dealing with
[34]
cancers
[36]
[Music]
[43]
genomic testing cooperative or gtc
[46]
is very unique because it is based on
[50]
cooperative business model
[53]
cooperative business models meaning
[56]
different laboratories can collaborate
[61]
and work together and this is what's
[63]
unique about
[64]
gtc
[65]
[Music]
[70]
the co-op model works through two models
[73]
one for small laboratories
[76]
where they send us the sample and we
[78]
perform the testings
[80]
the second models for larger
[82]
laboratories
[84]
large practice hematology groups
[87]
or oncology groups or larger
[91]
hospitals where we establish a wet lab
[94]
in their facilities and we perform the
[98]
analytical part on
[100]
the testing when it is done in their
[102]
facilities
[103]
[Music]
[108]
cost-effectiveness in our work is
[111]
achieved
[112]
through two ways first by
[115]
having cooperative groups our volume
[119]
is high therefore our cost is level
[123]
in exchange sequencing economy of scale
[126]
is very important
[127]
the second way for reducing cost is by
[131]
implementing algorithm
[134]
softwares based on deep learning and
[137]
artificial intelligence
[139]
and analyzing the data generated from
[141]
our exchange sequencing
[143]
and interoperating the data generated
[146]
from our next string sequencing
[150]
[Music]
[154]
we are using artificial intelligence in
[156]
analyzing zinc extreme sequencing data
[159]
as well as in developing models
[163]
for classification of diseases
[166]
and subclassification of diseases as
[169]
well as
[170]
for predicting outcomes
[174]
and therapy
[177]
[Music]
[180]
our business model is very disruptive to
[183]
the business
[184]
of exchange sequencing and diagnostics
[188]
we are the first laboratory that is
[191]
based on
[192]
cooperations rather than on competing
[196]
between different laboratories this is a
[198]
unique and disruptive
[200]
approach never done before to have
[203]
different laboratories
[204]
working together to offer better science
[208]
and better innovation for the patients
[211]
and
[211]
for the health system as a whole
[214]
[Music]
[217]
our reports are very comprehensive it
[220]
includes
[222]
complete analysis of the details
[225]
explanation
[226]
about the biological abnormalities we
[228]
provide diagnosis
[230]
as well as classifications we also
[233]
provide
[234]
recommendations for therapeutic
[237]
approaches
[237]
based on the findings
[240]
we also provide a list of clinical
[244]
trials
[245]
that might be dependent on the findings
[249]
of
[249]
the abnormalities in the patients as
[252]
well as
[253]
overall summary for our test
[261]
we are unique by being complementary to
[264]
the
[265]
community-based laboratories
[268]
small level operators cannot afford
[272]
or it is not practical to
[275]
establish mixing sequencing
[278]
facilities with sophisticated
[282]
instrumentations
[283]
as well as computers and scientists and
[287]
expertise
[288]
we complement them by providing
[291]
all this as extinction for them and
[295]
work with them and listen to their needs
[297]
educate them
[299]
and help the local physicians
[307]
the business model of gtc is very
[310]
amenable
[311]
and very useful for setting up companion
[315]
testing
[316]
based on ldt because
[319]
with the co-op model we can
[323]
technology by doing course validation
[326]
between different laboratories who
[328]
belong to the
[329]
memberships of the co-op and
[332]
that will allow multiple laboratories
[335]
to offer the ldt test if it is companion
[339]
testing
[340]
with similar standardizations
[343]
and similar quality
[352]
[Music]
[359]
[Music]
[365]
you
Most Recent Videos:
You can go back to the homepage right here: Homepage